Colorectal neoplasm
Conditions
Interventions
After obtaining consent, colorectal endoscopic submucosal dissection (colorectal ESD) is performed according to the usual clinical path (4 days/3 nights) currently in operation at Showa University Nor
Sponsors
Digestive disease center, Showa University Northern Yokohama Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients aged 18 years or older undergoing colorectal ESD who consented to this study
Exclusion criteria
Exclusion criteria: 1. Contraindications to ESD (e.g., inability to take appropriate anticoagulation or antiplatelet withdrawal medications, poor general condition, etc.) 2. Patients with residual or recurrent disease after endoscopic treatment 3. Cases in which the lesion is expected to be deeper than T2 before treatment 4. Cases of high ESD difficulty such as anastomosis, diverticulum, appendiceal orifice, ileal valve, and anal canal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vessel recognition rate (percentage of frames in which vessels were identified with an IoU index of 0.5 or higher) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. average tumor diameter, average treatment time, en bloc resection rate, pathological depth, perforation rate, posterior hemorrhage rate 2. muscle layer recognition rate 3. submucosal layer recognition rate 4. hemorrhage point recognition rate | — |
Countries
Japan
Contacts
Public ContactTatsuya Sakurai
Showa University Northern Yokohama Hospital Digestive disease center
Outcome results
None listed